Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In an accompanying editorial, Janani Rangaswami, MD (Washington DC Veterans Affairs Medical Center), and colleagues say the findings represent a key opportunity to intensify CV-kidney therapies in real-world practice in high-risk CKD even without overt CVD being present, given comparable event rates and benefits from therapies. The numbers needed to treat to prevent one primary kidney outcome at 3 years amounted to 22 in those with ASCVD, 13 in those with HF, and 17 in those with a PREVENT score 20%
This is the 12th closest exoplanet to us ever found, and the closest planet larger than Jupiter
Dont fear the reaper: the role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapy
In the UK, tirzepatide for weight management in adults with obesity or overweight with weight-related comorbidities is marketed as Zepbound, not Mounjaro
US$ 29.93
US$ 27.87
US$ 27.12
US$ 22.94
